Market Tracker

10/20 6:25am ET

Cytokinetics Inc (NASDAQ:CYTK)

14.80
Delayed Data
As of Oct 19
 -0.55 / -3.58%
Today’s Change
8.77
Today|||52-Week Range
17.20
+21.81%
Year-to-Date

Today’s Trading

Previous close15.35
Today’s open15.30
Day’s range14.65 - 15.43
Volume453,866
Average volume (3 months)466,723
Market cap$794.3M
Dividend yield--
Data as of 10/19/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-739.19%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+271.30%
P/E ratioNM
Price/Sales4.86
Price/Book6.38

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...+0.05+0.31%
FLXNFlexion Therapeutics...-0.55-2.27%
ACRSAclaris Therapeutics...-0.40-1.48%
AKBAAkebia Therapeutics ...-0.22-1.22%
Data as of 10/19/2017

Financials

Next reporting dateOctober 27, 2017
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$106.4M
Annual profit (last year)$16.5M
Net profit margin15.46%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer &
Senior Vice President
Ching Jaw
Corporate headquarters
South San Francisco, California

Forecasts